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Objective Oxidative stress has been implicated in the
pathogenesis of hypertension and its complications
through alterations in nitric oxide (NO) metabolism. This
study was designed to investigate whether a relationship
exists between phagocytic nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase-dependent
superoxide anion (•O22) production and NO generation in
patients with essential hypertension.
Methods Superoxide production was assayed by
chemiluminescence under baseline and stimulated
conditions on mononuclear cells obtained from
hypertensives (n 51) and normotensives (n 43). NO
production was evaluated by determining serum NO
metabolites, nitrate plus nitrite (NOx).
Results Although there were no differences in baseline
•O22 production between normotensives and
hypertensives, the •O22 production in phorbol myristate
acetate (PMA)-stimulated mononuclear cells was
increased (P < 0.05) in hypertensives compared with
normotensives. The PMA-induced •O22 production was
completely abolished by apocynin, a specific inhibitor of
NADPH oxidase. Moreover, stimulation of •O22 production
by angiotensin II and endothelin-1 was higher (P < 0.05) in
cells from hypertensives than in cells from normotensives.
In addition, diminished (P < 0.001) serum NOx was
detected in hypertensives compared with normotensives.
Interestingly, an inverse correlation (r 0.493, P < 0.01)
was found between •O22 production and NOx in
hypertensives.
Conclusions Generation of •O22 mainly dependent on
NADPH oxidase is abnormally enhanced in stimulated
mononuclear cells from hypertensives. It is suggested that
this alteration could be involved in the diminished NO
production observed in these patients. J Hypertens
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Introduction
A number of findings support the notion that super-
oxide anion (•O2) plays an important role in the
pathophysiology of cardiovascular diseases, including
essential hypertension [1]. An enhanced generation of
•O2 may cause a loss of nitric oxide (NO) production,
which leads, among other consequences, to endothelial
dysfunction [2]. The nicotinamide adenine dinucleo-
tide phosphate (NAD(P)H) oxidase system is consid-
ered to be the most important source of •O2 in
vascular cells [3,4]. Several studies have demonstrated
the involvement of vascular NAD(P)H oxidase in
experimental and clinical hypertension. In rats made
hypertensive by chronic angiotensin (Ang) II infusion,
vascular NAD(P)H oxidase-dependent •O2 production
is dramatically increased [5]. On the other hand, the
enhanced •O2 production present in the aorta of
spontaneously hypertensive rats (SHR) and deoxycorti-
costerone acetate-salt hypertensive rats is associated
with increased NAD(P)H oxidase activity [6,7]. Re-
cently, increased NAD(P)H oxidase-dependent •O2
production has been described in smooth muscle cells
from resistance arteries of hypertensives [8].
NADPH oxidase is also the major inducible source of
•O2 in phagocytic cells, including lymphocytes, mono-
cytes and neutrophils [9,10]. Although increased •O2
production in neutrophils from hypertensives has been
found by several authors [11–13], no changes in this
parameter were reported by others [14,15]. In addition,
the enzymatic source of •O2 was not clearly demon-
strated in these studies. Besides, other phagocytic cells
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may also be involved in the pathophysiology of hyper-
tension. An association of endothelial dysfunction with
subendothelial monocyte/macrophage infiltration has
been reported in SHR [16]. In addition, recent data
suggest that infiltration of the kidney by lymphocytes
and monocytes/macrophages play a role in the develop-
ment of hypertension in SHR through mechanisms
involving enhanced •O2 production [17]. Moreover,
available clinical data indicate that peripheral mono-
cytes/macrophages and lymphocytes are activated in
hypertensives compared with normotensives [18].
Therefore, we have hypothesized that an association
may exist between •O2 overproduction by monocytes
and lymphocytes and diminished NO production in
patients with essential hypertension. To test this hy-
pothesis NADPH oxidase-dependent •O2 production
in peripheral mononuclear cells, monocytes and lym-
phocytes, as well as the serum concentration of NO
metabolites (NOx), an index of systemic NO genera-
tion, were evaluated in hypertensives and normoten-
sives.
Methods
The study population consisted of two groups of
subjects who attended for routine medical examination
at the University Clinic of Navarra. The hypertensive
group consisted of 51 patients with repeatedly docu-
mented elevated systolic blood pressure (SBP) .
139 mmHg and/or diastolic blood pressure (DBP) .
89 mmHg. Antihypertensive medication was reported
by 22 patients (43%) as monotherapy or in combination.
The normotensive group consisted of 43 apparently
healthy subjects. All patients had appropriate clinical
and laboratory evaluations to exclude hypertension
secondary to other disorders [19]. Blood samples were
collected after an overnight (12–14 h) fast, and plasma
glucose, serum total, low-density lipoprotein (LDL)
and high-density lipoprotein (HDL) cholesterol, trigly-
ceride and C-reactive protein were determined by
standard laboratory protocols. All subjects gave written
informed consent to participate in the study, and the
Institutional Review Committee of the University
Clinic approved the protocol. The study conformed to
the principles of the Helsinki Declaration.
Preparation of phagocytic cells
Phagocytic cells were isolated from blood samples
obtained by a Ficoll-Hypaque gradient. Briefly, blood
samples (15 ml) obtained from each subject in ethyl-
enediaminetetra-acetic acid (EDTA) K3 tubes were
diluted with physiological serum (1 : 1) and the mixture
was layered on 15 ml of LymphoprepTM (Axis-Shield
PoC AS, Oslo, Norway) and then centrifuged for
20 min at room temperature and 1000 g. The interface
of phagocytic cells was carefully aspirated and washed
twice in physiological serum through centrifugation for
10 min at room temperature and 300 g. The pellet was
then resuspended in PBS (Gibco BRL, Paisley, Scot-
land, UK) ready for use. Mononuclear cells were
counted in a Neubauer chamber. To obtain reproduci-
ble data soft agitation at 378C of the final cell suspen-
sion was necessary to avoid cell aggregation. On the
other hand, this agitation was soft enough to avoid
endogenous stimulation.
Measurement of •O22 production in intact cells
Luminescence assays with lucigenin (10 mol/l; Sigma,
St Louis, Missouri, USA) as the electron acceptor were
used to measure •O2 production in 4 3 105 mono-
nuclear cells that were incubated at 378C for 30 min
alone or in presence of stimulus or inhibitors. The
reaction was started by the addition of lucigenin to cell
samples. Luminescence was measured every 11 s for
5 min in a tube luminometer (Berthold Detection
System, Sirius, Pforzheim, Germany). A buffer blank
was subtracted from each reading. The determinations
were performed under baseline conditions and also
after maximum stimulation by the protein kinase C
(PKC) activator, phorbol myristate acetate (PMA, 2 mg/
l, Sigma) at 378C. A kinetic study of baseline and
stimulated mononuclear cells response was carried out
and the value of the area under the curve was used to
quantify chemiluminescence. Data are expressed as
relative light units produced per second. In some
experiments, the effect of diphenylene iodonium (DPI,
5 mol/l; Sigma), a flavoprotein inhibitor, and apocynin
(2.5 3 103 mol/l; Calbiochem, Darmstadt, Germany), a
specific intracellular inhibitor of NADPH oxidase as-
sembly, were studied [20,21]. To verify the specificity
of the lucigenin assay for •O2 production, the effect of
superoxide dismutase (SOD, 10000 U/ml, Sigma), an
enzymatic scavenger of •O2, was examined.
Although lucigenin concentration was low enough to
avoid autoxidation, the measurements were validated
against an independent measurement of •O2 produc-
tion using SOD-inhibitable ferrycytochrome c reduc-
tion. Mononuclear cells (4 3 105) were incubated in
500 l of buffer containing ferrycytochrome C (80
mol/l; Sigma) at 378C for 60 min in the presence or
absence of SOD (10000 U/ml, Sigma) and finally the
absorbance was measured at 550 nm. The PMA-stimu-
lated production measured by lucigenin-enhanced
chemiluminescence was closely related with measure-
ments determined in parallel by ferricytochrome c
reduction.
In some experiments •O2 production in mononuclear
cells was analysed in response to physiological agonist,
such as Ang II (0.1 mol/l; Sigma) and endothelin
(ET)–1 (0.01 mol/l, Sigma). Furthermore, the up-
stream signalling pathways involved in NADPH oxi-
dase-mediated •O2 production were also investigated
with specific inhibitors of PKC (bisindolinmalenide
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(BIS) I, 10 mol/l, Calbiochem), phosphatidylinositol-
3-kinase (wortmannin, 1 mol/l, Sigma), MEK (PD
98059, 50 mol/l; Calbiochem), p38 MAPK (SB 203580,
1 mol/l, Sigma) and tyrosine kinase (tyrphostin,
1 mol/l, Sigma).
Determination of serum NOx
Serum samples collected after an overnight (12–14 h)
fast were prepared after centrifugation blood samples.
Nitrate and nitrite (NO2
/NO3) are stable NO meta-
bolites and their serum concentration reflects systemic
NO production [22]. After serum ultrafiltration, by
means of centrifugation at 14 000 g for 20 min and
filters with a cut-off of 30 kDa, NOx concentration
was evaluated directly from the supernatant using a
colorimetric assay based on Griess reaction (Cayman
Chemical Company, Ann Arbor, Michigan, USA). The
absorbance of the samples was determined at 540-nm
wavelength and compared with those of known concen-
trations of sodium nitrite.
Statistical analysis
Data are reported as means  standard error (SEM).
Statistical differences between mean values were tested
by Student’s t test for unpaired data once normality
was demonstrated (Shapiro–Wilk test); otherwise a
Mann–Whitney U test was used. When more than two
groups were analysed Kruskal-Wallis followed by a
Mann-Whitney U test was employed. Correlation be-
tween continuously distributed variables was analysed
by calculation of the linear regression and correlation
coefficients. The significant level for all tests was taken
as P , 0.05.
Results
The clinical characteristics of the studied subjects are
summarized in Table 1. Hypertensives were older than
normotensives. No differences were found between
normotensives and hypertensives with regard to gender,
frequency of smoking, body mass index and prevalence
of diabetes mellitus or hypercholesterolemia. The va-
lues of blood pressure were higher in the hypertensives
than in the normotensives. As expected, and since the
antihypertensive treatment was ineffective in treated
patients, no differences were found in blood pressure
values between treated and untreated hypertensive
patients.
Preliminary experiments showed that PMA (2 mg/l)
achieved the maximum •O2 production after 10 min
of incubation. Concentration and time of incubation
was determined after dose– and time–response curves
had been constructed (data not shown). The PMA-
stimulated •O2 production was inhibited by DPI
(5 mol/l) and apocynin (2.5 3 103 mol/l). SOD (10000
U/ml) also abolished the cellular-induced increase in
chemiluminescence PMA-stimulated conditions (Fig.
1). No differences with basal levels of chemilumin-
escence derived from unstimulated cells were observed.
Thus, these results suggest that the enzymatic complex
of NADPH oxidase may be the enzymatic source of
•O2 from mononuclear cells in the conditions of the
present study.
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Table 1 Clinical, demographic and biochemical characteristics of
normotensive subjects and hypertensive patients
Normotensives Hypertensives P
Age (years) 54.5  1.9 61.2  1.3 0.016
Gender (M/F) 29/14 38/13 0.445
BMI (kg/m2) 28.5  0.4 29.8  0.6 0.213
Smoking (yes/no) 17/26 15/36 0.164
Diabetes mellitus (yes/no) 10/33 15/36 0.180
Hypercholesterolemia (yes/no) 22/21 26/25 0.777
SBP (mmHg) 122.1  2.1 150.1  1.9 0.000
DBP (mmHg) 78.9  1.3 91.5  1.2 0.000
MAP (mmHg) 94.2  1.2 110.5  1.0 0.000
PP (mmHg) 45.1  1.4 59.5  2.0 0.000
C-reactive protein (mg/dl) 0.29  0.03 0.32  0.02 0.635
Glucose (mg/dl) 98  2 103  2 0.075
Total cholesterol (mg/dl) 229  6 234  5 0.680
HDL-cholesterol (mg/dl) 47  2 51  2 0.110
LDL-cholesterol (mg/dl) 158  5 161  4 0.885
Triglyceride (mg/dl) 111  8 112  7 0.775
Values are mean  SEM or number of subjects. BMI, body mass index; SBP,
systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial
pressure; PP, pulse pressure; HDL, high-density lipoproteins; LDL, low-density
lipoproteins.
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Fig. 1
Effects of diphenylene iodonium (DPI; 5 mol/l), apocynin (2.5 3 103
mol/l) and superoxide dismutase (SOD; 10 000 U/ml) on phorbol
myristate acetate (PMA)-stimulated •O2 generation assayed in control
conditions. Mononuclear cells were stimulated for 10 min with PMA
(2 mg/l) before lucigenin (10 mol/l) was added. Data are expressed as
mean þ standard error (SE). RLU/s, relative light units per second.
*P , 0.01 versus control.
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The values of baseline and PMA-stimulated •O2
production in mononuclear cells from hypertensives
and normotensives are shown in Figure 2. The mean
levels of •O2 production from non-stimulated mono-
nuclear cells were similar in the two groups of subjects.
The addition of PMA stimulated •O2 production both
in normotensives (134.9  18.9 versus 1320.7  148.1
relative light units (RLU)/s; P , 0.001) and hyper-
tensives (131.7  16.5 versus 1748.7  147.4 RLU/s;
P , 0.001). The magnitude of this stimulation was
higher (P , 0.05) in cells from hypertensives than in
cells from normotensives. Since hypertensives were
older than normotensives, and in order to discard an
effect of age on PMA-stimulated •O2 production, this
parameter was evaluated across quartiles of age, in the
whole population and in the hypertensive group and no
significant tendency was found. On the other hand,
there were no differences in the values of PMA-
stimulated NADPH oxidase-dependent •O2 produc-
tion between treated and untreated (n ¼ 22, 1562  196
RLU/s versus n ¼ 29, 1910  215 RLU/s, respectively,
P ¼ 0.261) hypertensives. As the study was not rando-
mized, nothing about the prophylaxis of the antihyper-
tensive therapy (doses, time of treatment.) was
controlled. Interestingly, we possessed information con-
cerning the ability of the antihypertensive agents to
interfere with the renin–angiotensin system. No differ-
ences were found in PMA-stimulated •O2 production
depending on the antihypertensive therapy.
Finally, and in order to check if the mononuclear cells
from hypertensives showed a higher response than
normotensives to physiological agonist, we evaluated
the •O2 production induced by Ang II (0.1 mol/l)
and ET-1 (0.01 mol/l). •O2 production was signifi-
cantly higher in hypertensives than in normotensives in
response to both Ang II (226.8  7.9 versus 130.1 
14.9 RLU/s; P , 0.05) and ET-1 (211.4  6.1 versus
133.8  15.1 RLU/s; P , 0.05) (Fig. 3).
Furthermore, we investigated the upstream signalling
pathways involved in the PMA-stimulated •O2 pro-
duction in a subgroup of individuals. BIS I (10 mol/l),
a protein kinase C (PKC) inhibitor, completely inhib-
ited •O2 production. Wortmannin 1 mol/l, inhibited
•O2 production by 80% and both, PD 98059 50 mol/l
and SB 203580 1 mol/l inhibited by 70% the effect
measured in the present study. Finally, tyrphostin
1 mol/l inhibited by 50%. No differences were found
in the effect of the tested inhibitors on •O2 produc-
tion between normotensives (n ¼ 10) and hypertensives
(n ¼ 10).
The NOx levels were lower (P , 0.001) in hyper-
tensives than in normotensives (Fig. 4). Again, there
were no differences in the values of NOx between
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Fig. 2
Baseline and phorbol myristate acetate (PMA)-stimulated •O2
generation in mononuclear cells obtained from normotensives (open
bars) and hypertensives (closed bars). Intact mononuclear cells were
incubated for 10 min with PMA (2 mg/l) and the rate of •O2
production was evaluated by lucigenin (10 mol/l) chemiluminescence.
Data are expressed as mean þ standard error (SE). RLU/s, relative light
units per second. *P, 0.05 versus normotensive controls.
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Fig. 3
Baseline and angiotensin (Ang) II (0.1 mol/l) and endothelin (ET)–1
(0.01 mol/l)-stimulated •O2 generation in mononuclear cells
obtained from normotensives (open bars, n ¼ 10) and hypertensives
(closed bars, n ¼ 10). The rate of •O2 production was evaluated by
lucigenin (10 mol/l) chemiluminescence. Data are expressed as
mean þ standard error (SE). RLU/s, relative light units per second.
*P , 0.05 versus normotensive controls.
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treated and untreated hypertensives (4.5  0.2 mol/l
versus 4.3  0.2 mol/l, respectively, P ¼ 0.261). An
inverse correlation was found between NOx concentra-
tion and PMA-stimulated •O2 generation in the
hypertensive population (Fig. 5).
Discussion
The major finding of this study is that NADPH
oxidase-dependent •O2 production is abnormally en-
hanced in mononuclear cells from hypertensive pa-
tients. The NADPH oxidase is a multicomponent
enzyme that has a membrane portion collectively
known as cytochrome b558 , that is inactive until it is
associated with the cytosolic components (see [9,10] for
review). Apocynin is a potent intracellular inhibitor of
the assembly of the NADPH oxidase upon stimulation,
since it impedes the assembly of the p47phox and
p67phox subunits within the membrane NADPH oxi-
dase complex [20,21]. This agent has no known inhibi-
tory effects upon the other potential sources of reactive
oxygen species [20]. Thus, our findings showing com-
plete inhibition of PMA-stimulated •O2 production
observed in the presence of apocynin strongly suggests
that the enzymatic complex of NADPH oxidase is the
source of •O2.
The exaggerated response to PMA of hypertensive
cells might be the result of a state of preactivation. In
fact, preactivated monocytes exhibit increased adher-
ence to endothelial cells and increased release of
cytokines upon stimulation in hypertensives [23–25].
Several potential stimulating factors of the NAD(P)H
oxidase enzymatic system deserve to be considered in
the setting of arterial hypertension. The role of humoral
factors in the upregulation of NAD(P)H oxidase activ-
ity has been extensively documented [26]. Ang II- and
ET-1-enhanced NAD(P)H oxidase activity has been
described in several kinds of cells, including smooth
muscle cells [27,28] and monocytes [23,29]. Our find-
ings showing a higher •O2 production in response to
Ang II and ET-1 in hypertensives than in normoten-
sives support a potential role of these factors in the
activation of mononuclear cells on the hypertensive
state. In addition, Ungvari et al. [30] have recently
demonstrated that mechanical stress associated with
high pressure induces •O2 production in isolated
arteries via stimulation of NADPH oxidase. The ques-
tion as to whether mechanical forces may also play a
role on phagocytic enzymatic system merits investiga-
tion. Nevertheless, our finding that PMA-stimulated
•O2 production is increased in those treated hyper-
tensives in whom blood pressure remains raised suggest
that mechanical forces may play an important regula-
tory role in the activation of phagocytic NADPH
oxidase. Additionally, previous works support that a
genetic background may also contribute to the activa-
tion of NAD(P)H oxidase [31–33].
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Serum levels of nitric oxide metabolites (NOx) in normotensive subjects
and hypertensive patients. Data are expressed as mean þ standard
error (SE). *P , 0.001 versus normotensive controls.
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Inverse correlation between phorbol myristate acetate (PMA)-
stimulated •O2 production and nitric oxide metabolites (NOx) in
hypertensive patients; y ¼ 6.61–0.00067x; r ¼ 0.493, P, 0.01. RLU/
s, relative light units per second.
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Underlying mechanisms for this increased •O2 pro-
duction are unclear, although data from several studies
suggest a potential role for p38 and ERK MAPKs,
tyrosin kinases and PKC [34–36]. Data here presented
support the involvement of all these pathways in the
regulation of NADPH oxidase-mediated •O2 produc-
tion in phagocytes. Moreover, PMA is thought to
stimulate NADPH oxidase to produce •O2 by activa-
tion of PKC. In accordance with this view, increased
PMA-stimulated •O2 production was blocked by BIS,
an inhibitor of PKC. The potential relevance of these
data is remarked by a number of findings showing that
hemodynamic and humoral factors, including Ang II
and ET-1, activate NADPH oxidase through PKC-
dependent mechanisms [30,37,38].
A second finding of this study is that the serum nitrate
plus nitrite concentration was lower in hypertensives
than in normotensives. This finding confirms previous
data reported by others in the hypertensive population
[39,40]. NO is rapidly oxidized to nitrite and then to
nitrate by oxygenated hemoglobin, molecular oxygen
and •O2, so the major oxidative metabolites are nitrite
and nitrate. Although NO is able to react with •O2 to
form peroxynitrate, this compound may lead to nitra-
tion of tyrosine or may isomerase to nitrates [41].
Nevertheless, serum nitrotyrosine levels were undetect-
able in our population (data not shown). Thus, NOx
measurements obtained in this study clearly reflect real
changes in NO generation. Impaired expression/activity
of endothelial NO synthase (eNOS) could cause the
diminished production of NO observed in hypertensives
(Reviewed in [42]). In addition, eNOS-mediated NO
production may be reduced when the enzyme is
deprived of its critical cofactor tetrahydrobiopterin or
its substrate L-arginine [43]. This phenomenon has
been referred to as eNOS uncoupling. Oxidation of
tetrahydrobiopterin by peroxynitrite may also lead to
uncoupling of eNOS [44]. Landmesser et al. [45] have
recently demonstrated that NAD(P)H oxidase is criti-
cally important in producing reactive oxygen species
that ultimately oxidize tetrahydrobiopterin in blood
vessels of hypertensive animals. Our finding of an
inverse correlation between NADPH oxidase-depen-
dent •O2 production and NO metabolites in hyper-
tensives supports this possibility. In agreement with
this, blockage of the -receptors inhibits the phagocytic
NADPH oxidase activity and prevents eNOS uncou-
pling in experimental hyperlipidemia [46].
The potential role of phagocytic NADPH oxidase in
the pathogenesis of hypertension is unclear. Several
groups have demonstrated an increased •O2 genera-
tion in neutrophils from hypertensives [11–13]. It has
also been reported that ROS production is increased in
immortalized lymphocytes from hypertensives [47].
Augmented infiltration of monocytes and lymphocytes
in the vascular wall of SHR, associated with enhanced
•O2 production that impair, among others, the en-
dothelial function have been demonstrated [16,17].
Thus, the findings here reported showing a higher
NADPH oxidase-dependent •O2 production in stimu-
lated mononuclear cells from hypertensives suggest that
infiltrated mononuclear cells may play a relevant role in
the development of oxidative stress in the vascular
wall, favouring endothelial dysfunction, among other
mechanisms, by an impaired NO production. Further
studies are required to demonstrate the molecular
evidence linking an increased •O2 generation with a
diminished NO production.
Some limitations of the present study should be
acknowledged. First, half of the patients were under
antihypertensive treatment but it was inadequate in
terms of blood pressure control and apparently it did
not influence •O2 or NO production. Second, oral
intake of NO2 and NO3 was not restricted in the
overall population although some authors have indi-
cated that dietary nitrates are eliminated from the
blood by urinary excretion after approximately 12 to
16 h, and therefore measurement of NOx in blood
collected after an overnight fast could reliably reflect
endogenous NO production [48]. Third, since the study
was performed in a small population, further studies in
larger samples are required to confirm the current
results.
In conclusion, this study demonstrates for the first time
that the production of •O2 by NADPH oxidase is
increased in PMA-stimulated mononuclear cells from
hypertensive patients. Furthermore, our results show an
association between exaggerated phagocytic NADPH
oxidase-dependent •O2 production and diminished
NO generation in these patients. Thus, it is tempting
to speculate that phagocytic NADPH oxidase might be
involved in diminished NO availability observed in
essential hypertension.
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